These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26024832)

  • 1. Is antenatal screening for hepatitis C virus cost-effective? A decade's experience at a London centre.
    Selvapatt N; Ward T; Bailey H; Bennett H; Thorne C; See LM; Tudor-Williams G; Thursz M; McEwan P; Brown A
    J Hepatol; 2015 Oct; 63(4):797-804. PubMed ID: 26024832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost impact of outreach testing and treatment for hepatitis C in an urban Drug Treatment Unit.
    Selvapatt N; Ward T; Harrison L; Lombardini J; Thursz M; McEwan P; Brown A
    Liver Int; 2017 Mar; 37(3):345-353. PubMed ID: 27566283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective hepatitis C seroprevalence screening in the antenatal setting-should we be screening antenatal women?
    Orkin C; Jeffery-Smith A; Foster GR; Tong CY
    BMJ Open; 2016 May; 6(5):e010661. PubMed ID: 27231001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine screening for hepatitis C in pregnancy is cost-effective in a large urban population in Ireland: a retrospective study.
    McCormick CA; Domegan L; Carty PG; Drew R; McAuliffe FM; O'Donohoe O; White N; Garvey P; O'Grady M; De Gascun CF; McCormick PA
    BJOG; 2022 Jan; 129(2):322-327. PubMed ID: 34706147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is adding HCV screening to the antenatal national screening program in Amsterdam, the Netherlands, cost-effective?
    Urbanus AT; van Keep M; Matser AA; Rozenbaum MH; Weegink CJ; van den Hoek A; Prins M; Postma MJ
    PLoS One; 2013; 8(8):e70319. PubMed ID: 23950920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing.
    Ward C; Tudor-Williams G; Cotzias T; Hargreaves S; Regan L; Foster GR
    Gut; 2000 Aug; 47(2):277-80. PubMed ID: 10896922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and Acceptability of Antenatal Hepatitis C Screening: A Pilot Study.
    Valamparampil J; Sira J; Brown M; Singhal S; Kelly D
    Can J Gastroenterol Hepatol; 2024; 2024():7696410. PubMed ID: 39229363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea.
    Kim DY; Han KH; Jun B; Kim TH; Park S; Ward T; Webster S; McEwan P
    PLoS One; 2017; 12(1):e0167770. PubMed ID: 28060834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic model of a birth cohort screening program for hepatitis C virus.
    McGarry LJ; Pawar VS; Panchmatia HR; Rubin JL; Davis GL; Younossi ZM; Capretta JC; O'Grady MJ; Weinstein MC
    Hepatology; 2012 May; 55(5):1344-55. PubMed ID: 22135116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
    Plunkett BA; Grobman WA
    Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost effectiveness of universal antenatal screening for HIV in New Zealand.
    Bramley D; Graves N; Walker D
    AIDS; 2003 Mar; 17(5):741-8. PubMed ID: 12646798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration.
    Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C: is there a case for universal screening in pregnancy?
    Martyn F; Phelan O; O'Connell M
    Ir Med J; 2011 May; 104(5):144-6. PubMed ID: 21736090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141).
    Deuffic-Burban S; Schwarzinger M; Obach D; Mallet V; Pol S; Pageaux GP; Canva V; Deltenre P; Roudot-Thoraval F; Larrey D; Dhumeaux D; Mathurin P; Yazdanpanah Y
    J Hepatol; 2014 Jul; 61(1):7-14. PubMed ID: 24650691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of novel regimens for the treatment of hepatitis C virus.
    Najafzadeh M; Andersson K; Shrank WH; Krumme AA; Matlin OS; Brennan T; Avorn J; Choudhry NK
    Ann Intern Med; 2015 Mar; 162(6):407-19. PubMed ID: 25775313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands.
    Eijsink JFH; Al Khayat MNMT; Boersma C; Ter Horst PGJ; Wilschut JC; Postma MJ
    Eur J Health Econ; 2021 Feb; 22(1):75-88. PubMed ID: 33064259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who to screen for hepatitis C? A cost-effectiveness study in Belgium of comprehensive hepatitis C screening in four target groups.
    Opstaele L; Bielen R; Bourgeois S; Moreno C; Nevens F; Robaeys G; Robaeys G; Van Vlierberghe H
    Acta Gastroenterol Belg; 2019; 82(3):379-387. PubMed ID: 31566325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streamlining the screening cascade for active Hepatitis C in Russia: A cost-effectiveness analysis.
    Jülicher P; Chulanov VP; Pimenov NN; Chirkova E; Yankina A; Galli C
    PLoS One; 2019; 14(7):e0219687. PubMed ID: 31310636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland.
    Bruggmann P; Negro F; Bihl F; Blach S; Lavanchy D; Müllhaupt B; Razavi H; Semela D
    Swiss Med Wkly; 2015; 145():w14221. PubMed ID: 26715488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-Term Effects and Long-Term Cost-Effectiveness of Universal Hepatitis C Testing in Prenatal Care.
    Tasillo A; Eftekhari Yazdi G; Nolen S; Schillie S; Vellozzi C; Epstein R; Randall L; Salomon JA; Linas BP
    Obstet Gynecol; 2019 Feb; 133(2):289-300. PubMed ID: 30633134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.